Hepatitis B News and Research

Latest Hepatitis B News and Research

Researchers find experimental compound to treat fibrotic diseases

Normal scar tissue forms to heal an internal wound and quietly retreats when the job is done. But in many common diseases - kidney, liver and lung fibrosis -- the scar tissue goes rogue and strangles vital organs. These diseases are largely untreatable and ultimately fatal.

13 Jul 2018

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.

12 Jul 2018

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.

9 Jul 2018

Researchers trace history of human Hepatitis B in the Bronze Age

Thanks to viral traces in the genomes of ancient people, researchers from South Ural State University were able to determine that man has been suffering from Hepatitis B since at least the Bronze Age.

9 Jul 2018

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

State prisons across the U.S. are failing to treat at least 144,000 inmates who have hepatitis C, a curable but potentially fatal liver disease, according to a recent survey and subsequent interviews of state corrections departments.

9 Jul 2018

Increase in marker of inflammation from mid to late life linked with dementia

Researchers at Johns Hopkins have added to evidence that rising and chronic inflammation as measured by a biomarker in the blood in middle and late age are linked to visible structural changes in the brains of people with poor cognition and dementia.

2 Jul 2018

Researchers develop inexpensive blood test to diagnose hepatitis B patients

A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa's poorest regions.

2 Jul 2018

Mathematical model assesses efficacy, cost-effectiveness of screening strategies for HCV

It is currently recommended in Europe that screening for hepatitis C virus should target people at high risk of infection.

2 Jul 2018

People with co-existing HCV and AUD experience greater psychiatric, immune problems

Infection with the hepatitis C virus is a contagious liver disease with symptoms that range from mild illness for a few weeks to serious, lifelong liver problems.

28 Jun 2018

Illicit drug supply at record heights

According to a 2018 World Drug report released by the United Nations Office on Drugs and Crime (UNODC) this week (26th June 2018) the supply of illicit drugs such as cocaine, opium and heroin have reached record heights.

28 Jun 2018

ABPI associated with NHS for 70 years in pharmaceutical research

In this special year, both the NHS and the Association of the British Pharmaceutical Industry are celebrating our respective 70th anniversaries. The histories of these two organizations have been inextricably linked since 1948 and our relationship with the NHS continues to go from strength to strength.

25 Jun 2018

Scientists discover secret to success of antiviral gene

It's been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying.

25 Jun 2018

If you’ve got hep C, spitting can be a felony

Last week, an Ohio man who has the hepatitis C virus was sentenced to 18 months in prison for spitting at Cleveland police and medics.

19 Jun 2018

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

An estimated 3.5 million people in the United States have chronic hepatitis C (HCV), according to the Centers for Disease Control and Prevention.

18 Jun 2018

Researchers uncover racial differences in debilitating itchy skin condition

An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.

14 Jun 2018

Video consultations boost survival rates of liver disease patients, study finds

For patients who live in rural areas, driving to see a specialist in a large city or at a university hospital can be challenging, if not impossible.

12 Jun 2018

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

A Trump administration effort to shift family planning funding toward groups that may not provide comprehensive services and away from organizations that provide abortions could cripple other federal efforts to curb an explosion in sexually transmitted diseases, some public health officials fear.

12 Jun 2018

Changes to the immune system remain even after recovery from HCV infection, shows study

Changes to the immune system remain many years after a hepatitis C infection heals, a new study by researchers at Karolinska Institutet, Sweden, and Hannover Medical School, Germany, shows.

11 Jun 2018

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Researchers from GeoVax have developed a flexible "Plug and Play" technology platform that delivers single-dose vaccines that fully protect against emerging infectious diseases such as Zika, Lassa fever, and Ebola.

11 Jun 2018

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.

7 Jun 2018

Hepatitis B News and Research

Latest Hepatitis B News and Research

Researchers find experimental compound to treat fibrotic diseases

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

Researchers trace history of human Hepatitis B in the Bronze Age

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

Increase in marker of inflammation from mid to late life linked with dementia

Researchers develop inexpensive blood test to diagnose hepatitis B patients

Mathematical model assesses efficacy, cost-effectiveness of screening strategies for HCV

People with co-existing HCV and AUD experience greater psychiatric, immune problems

Illicit drug supply at record heights

ABPI associated with NHS for 70 years in pharmaceutical research

Scientists discover secret to success of antiviral gene

If you’ve got hep C, spitting can be a felony

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

Researchers uncover racial differences in debilitating itchy skin condition

Video consultations boost survival rates of liver disease patients, study finds

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

Changes to the immune system remain even after recovery from HCV infection, shows study

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Hepatitis B News and Research

Latest Hepatitis B News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in